Related Experiment Video
Updated: Jun 18, 2026

A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation
Published on: February 28, 2012
Implantable cardioverter-defibrillators
1Cardiology Division, Department of Medicine, New York Medical College, Valhalla, NY 10595, USA. wsaronow@aol.com
Insights
The automatic implantable cardioverter-defibrillator (AICD) offers effective treatment for life-threatening heart rhythms. Patients with AICDs benefit from specific pacing and medication strategies for optimal outcomes.
Area of Science:
- Cardiology
- Medical Devices
- Electrophysiology
Background:
- Life-threatening ventricular arrhythmias like ventricular tachycardia and fibrillation require advanced treatment.
- The automatic implantable cardioverter-defibrillator (AICD) is a key therapeutic option for these conditions.
Purpose of the Study:
- To discuss the American College of Cardiology/American Heart Association class I, IIa, and III indications for AICD implantation.
- To outline optimal management strategies for patients with AICDs.
Main Methods:
- Review of current clinical guidelines and indications for AICD.
- Analysis of recommended pacing and pharmacologic therapies for AICD patients.
Main Results:
- AICD implantation is indicated for specific patient groups based on established guidelines.
- Biventricular pacing is recommended over dual-chamber rate-responsive pacing for AICD patients.
- Pharmacologic management should include beta blockers, statins, and ACE inhibitors or ARBs.
Conclusions:
- AICD is the most effective treatment for specific malignant ventricular arrhythmias.
- Optimal patient management involves appropriate pacing and guideline-directed medical therapy.
Abstract:
The automatic implantable cardioverter-defibrillator (AICD) is the most effective treatment for patients with life-threatening ventricular tachycardia or ventricular fibrillation. The American College of Cardiology/American Heart Association class I, IIa, and III indications for an AICD are discussed. Patients with AICDs should be treated with biventricular pacing, not with dual-chamber rate-responsive pacing at a rate of 70/minute. Patients with AICDs should be treated with beta blockers, statins, and angiotensin-converting enzyme inhibitors or angiotensin receptor blockers.
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy II: Dilated Cardiomyopathy
Dysrhythmias VI: Management of Dysrhythmias
Cardiopulmonary Resuscitation III: AED Use
Heart Failure VI: Adjunct Therapies
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
